The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding

Academic Article


  • Objective: To present a case report of a patient with Noonan syndrome who developed life-threatening gastrointestinal bleeding shortly after cardiac surgery that was successfully treated with recombinant factor VIIa. Design:Case report. Setting: Pediatric intensive care unit of a children's hospital. Patient: Ten-month-old with Noonan syndrome and massive gastrointestinal bleeding resulting in severe hypovolemic shock. Interventions: Recombinant factor VIIa was used in this patient's severe bleeding associated with Noonan syndrome after no other supportive measures were successful. Measurements and main results: Recombinant Factor VIIa significantly decreased the patient's bleeding and allowed his hypovolemic shock to improve. Ultimately, the patient made a complete recovery. Conclusions: Noonan syndrome has a constellation of both cardiac and noncardiac malformations including an increased risk of bleeding, and recombinant factor VIIa is an important agent in the treatment of significant bleeding. Copyright © 2005 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Pubmed Id

  • 8183046
  • Author List

  • Tofil NM; Winkler MK; Watts RG; Noonan J
  • Start Page

  • 352
  • End Page

  • 354
  • Volume

  • 6
  • Issue

  • 3